title: Additional effects of irbesartan when compared to captopril in the prevention of post-infarction left ventricular dilatation.
authors.affiliation: Institute of Cardiology, N. D. Strazhesko Ukrainian Academy of Medical Sciences, Kiev.
authors.forename: Alexander N
authors.initials: AN
authors.lastname: Parkhomenko
authors.forename: Oleg I
authors.initials: OI
authors.lastname: Irkin
authors.forename: Sergey P
authors.initials: SP
authors.lastname: Kushnir
authors.forename: Zhanna V
authors.initials: ZV
authors.lastname: Bryl
authors.forename: Oksana
authors.initials: O
authors.lastname: Soliarik
authors.forename: Lilia V
authors.initials: LV
authors.lastname: Shkliar
mesh_terms: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D002216:Captopril / Q000627:therapeutic use*; D004108:Dilatation, Pathologic; D006352:Heart Ventricles / Q000473:pathology*; D006801:Humans; D000077405:Irbesartan; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D013777:Tetrazoles / Q000627:therapeutic use*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001713:Biphenyl Compounds; D013777:Tetrazoles; D002216:Captopril; D000077405:Irbesartan